|
x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
California
|
95-3280412
|
|
(State
or other jurisdiction
of
incorporation or organization)
|
(I.R.S.
Employer
Identification
No.)
|
|
15350
Sherman Way, Suite 350
Van
Nuys, California
|
91406
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Large
Accelerated Filer o
|
Accelerated
Filer o
|
Non-Accelerated
Filer ¨
|
Smaller
reporting company T
|
|
a.
|
Recorded,
processed, summarized and reported within the time period specified in the
Securities and Exchange Commission’s rules and forms;
and
|
|
b.
|
Accumulated
and communicated to our management, including our principal executive and
principal financial officer, to allow timely decisions regarding required
disclosure.
|
|
·
|
Potential impact on the accuracy
of the financial statements
(30%)
|
|
·
|
Nature and complexity
(20%)
|
|
·
|
Degree of subjectivity
(20%)
|
|
·
|
Potential for fraud
(20%)
|
|
·
|
Previously identified errors
(10%)
|
|
·
|
developed
a list of identified control
weaknesses;
|
|
·
|
developed
action plans to correct each identified
weakness;
|
|
·
|
held
meetings to discuss the allocation of resources and timelines to complete
each action plan;
|
|
·
|
instituted
other mitigating controls over revenue recognition and over the use of
spreadsheets to enhance the control environment pertaining to these areas
of material weakness; and
|
|
·
|
evaluated
and standardized SOX testing and
controls.
|
|
·
|
evaluate
accounting and control systems to identify opportunities for enhanced
controls;
|
|
·
|
recruit
and hire additional staff to provide greater segregation of
duty;
|
|
·
|
evaluate
the need for other employee
changes;
|
|
·
|
expand
executive management's ongoing communications regarding the importance of
adherence to internal controls and company
policies;
|
|
·
|
implement
an internal auditing function at HemaCare and its subsidiaries;
and
|
|
·
|
evaluate
such other actions as the Company’s advisors may
recommend.
|
Exhibits
|
3.1
|
Restated
Articles of Incorporation of the Registrant incorporated by reference to
Exhibit 3.1 to Form 10-K of the Registrant for the year ended
December 31, 2002.
|
||
3.2
|
Amended
and Restated Bylaws of the Registrant, as amended, incorporated by
reference to Exhibit 3.1 to Form 8-K of the Registrant filed on
March 28, 2007.
|
||
10.1
|
Settlement
Agreement and Mutual Release entered into as of August 26, 2008, between
HemaCare Corporation and Joseph Mauro and Valentin Adia, incorporated by
reference to Exhibit 99.1 to Form 8-K of the Registrant filed on September
5, 2008.
|
||
11
|
Net
Income per Common and Common Equivalent Share, incorporated by reference
to Exhibit 11 to Form 10-Q of the Registrant for the quarter ended
September 30, 2008.
|
||
31.1
|
Certification
Pursuant to Rule 13a-14(a) Under the Securities Exchange Act,
incorporated by reference to Exhibit 31.1 to Form 10-Q of the Registrant
for the quarter ended September 30, 2008.
|
||
31.1.1
|
Certification
Pursuant to Rule 13a-14(a) Under the Securities Exchange
Act.
|
||
31.2
|
Certification
Pursuant to Rule 13a-14(a) Under the Securities Exchange Act,
incorporated by reference to Exhibit 31.2 to Form 10-Q of the Registrant
for the quarter ended September 30, 2008.
|
||
31.2.1
|
Certification
Pursuant to Rule 13a-14(a) Under the Securities
Exchange.
|
||
32.1
|
Certification
Pursuant to 18 U.S.C. 1350 and Rule 13a-14(b) Under the
Securities Exchange Act of 1934, incorporated by reference to Exhibit 31.2
to Form 10-Q of the Registrant for the quarter ended September 30,
2008.
|
||
32.1.1
|
Certification
Pursuant to 18 U.S.C. 1350 and Rule 13a-14(b) Under the
Securities Exchange Act of 1934.
|
Date
|
April
3, 2009
|
Hemacare
Corporation
|
||
(Registrant)
|
||||
By:
|
/s/
John Doumitt
|
|||
John
Doumitt, Chief Executive
Officer
|
||||
By:
|
/s/
Robert S. Chilton
|
|||
Robert
S. Chilton, Chief
Financial
Officer
|
3.1
|
Restated
Articles of Incorporation of the Registrant incorporated by reference to
Exhibit 3.1 to Form 10-K of the Registrant for the year ended
December 31, 2002.
|
||
3.2
|
Amended
and Restated Bylaws of the Registrant, as amended, incorporated by
reference to Exhibit 3.1 to Form 8-K of the Registrant filed on
March 28, 2007.
|
||
10.1
|
Settlement
Agreement and Mutual Release entered into as of August 26, 2008, between
HemaCare Corporation and Joseph Mauro and Valentin Adia, incorporated by
reference to Exhibit 99.1 to Form 8-K of the Registrant filed on September
5, 2008.
|
||
11
|
Net
Income per Common and Common Equivalent Share, incorporated by reference
to Exhibit 11 to Form 10-Q of the Registrant for the quarter ended
September 30, 2008.
|
||
31.1
|
Certification
Pursuant to Rule 13a-14(a) Under the Securities Exchange Act,
incorporated by reference to Exhibit 31.1 to Form 10-Q of the Registrant
for the quarter ended September 30, 2008.
|
||
31.1.1
|
Certification
Pursuant to Rule 13a-14(a) Under the Securities Exchange
Act.
|
||
31.2
|
Certification
Pursuant to Rule 13a-14(a) Under the Securities Exchange Act,
incorporated by reference to Exhibit 31.2 to Form 10-Q of the Registrant
for the quarter ended September 30, 2008.
|
||
31.2.1
|
Certification
Pursuant to Rule 13a-14(a) Under the Securities
Exchange.
|
||
32.1
|
Certification
Pursuant to 18 U.S.C. 1350 and Rule 13a-14(b) Under the
Securities Exchange Act of 1934, incorporated by reference to Exhibit 31.2
to Form 10-Q of the Registrant for the quarter ended September 30,
2008.
|
||
32.1.1
|
Certification
Pursuant to 18 U.S.C. 1350 and Rule 13a-14(b) Under the
Securities Exchange Act of
1934.
|